Gossamer Bio, Inc. (GOSS) NASDAQ
0.20
+0.0021(+1.06%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 708.41M |
| Enterprise Value | 872.65M |
| P/E Ratio | -0.26 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.85 |
| Price/Book Ratio | -0.29 |
| Enterprise/Revenue | 3.76 |
| Enterprise/EBITDA | -1.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -3.25 |
| Operating Margin | -3.22 |
Management Effectiveness
| Return On Assets | -1.4 |
| Return On Equity | 1.75 |
Income Statement
| Revenue | 48.47M |
| Revenue/Share | 0.24 |
| Gross Profit | 47.47M |
| EBITDA | -162.25M |
| Net Income | -170.37M |
| Diluted EPS | -0.75 |
Balance Sheet
| Total Cash | 99.22M |
| Total Cash/Share | 0.42 |
| Total Debt | 202.93M |
| Total Debt/Equity | -1.26 |
| Current Ratio | 2.2 |
| Book Value Per Share | -0.69 |
Price History
| 52-Week Change | -82.74 |
| 52-Week High | 3.87 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 0.33 |
| Moving Average 200 Days | 1.89 |
Statistics
| Average Volume | 10.85M |
| Shares Outstanding | 234.7M |
| % Held by Institutions | 73.09 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
